Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more
Remed Co.Ltd - Asset Resilience Ratio
Remed Co.Ltd (302550) has an Asset Resilience Ratio of 11.71% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Remed Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Remed Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩6.48 Billion | 11.71% |
| Total Liquid Assets | ₩6.48 Billion | 11.71% |
Asset Resilience Insights
- Moderate Liquidity: Remed Co.Ltd has 11.71% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Remed Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Remed Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Remed Co.Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Remed Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 18.08% | ₩10.68 Billion | ₩59.06 Billion | +10.19pp |
| 2023-12-31 | 7.89% | ₩4.35 Billion | ₩55.06 Billion | -31.31pp |
| 2022-12-31 | 39.20% | ₩30.63 Billion | ₩78.13 Billion | -7.97pp |
| 2021-12-31 | 47.17% | ₩36.42 Billion | ₩77.20 Billion | -9.50pp |
| 2020-12-31 | 56.67% | ₩41.64 Billion | ₩73.47 Billion | +13.13pp |
| 2019-12-31 | 43.54% | ₩15.22 Billion | ₩34.95 Billion | +14.33pp |
| 2018-12-31 | 29.21% | ₩6.28 Billion | ₩21.51 Billion | +6.47pp |
| 2017-12-31 | 22.74% | ₩2.86 Billion | ₩12.59 Billion | -- |